These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Evaluation of efficiency of the drug treatment of patients with toxic goiter]. Zelinskiĭ BA; Slobodnianik OA Vrach Delo; 1978 Apr; (4):115-8. PubMed ID: 78584 [No Abstract] [Full Text] [Related]
25. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma]. Hansen PE Ugeskr Laeger; 1983 Mar; 145(13):980-2. PubMed ID: 6190284 [No Abstract] [Full Text] [Related]
26. [Antithyroid and TSH-suppressive treatment in Basedow disease?]. Mann K; Hörmann R Internist (Berl); 1998 Jun; 39(6):610-2. PubMed ID: 9677519 [No Abstract] [Full Text] [Related]
27. [Reduced antithyroid agents as a result of radioiodine therapy?]. Maka D; Schicha H; Körber C; Schneider P; Reiners C Nuklearmedizin; 2000; 39(2):N25-6. PubMed ID: 10768174 [No Abstract] [Full Text] [Related]
28. Early treatment with low fixed dose (5 mCi) radioiodine therapy is effective in Indian subjects with Graves' disease. Sanyal D; Mukhhopadhyay P; Pandit K; Chatterjee J; Raychaudhuri M; Mukherjee S; Chowdhury S J Indian Med Assoc; 2008 Jun; 106(6):360-1, 372. PubMed ID: 18839646 [TBL] [Abstract][Full Text] [Related]
29. Drug treatment in thyroid disease. Mills LC Semin Drug Treat; 1974; 3(4):377-402. PubMed ID: 4132535 [No Abstract] [Full Text] [Related]
30. Remission of Graves' hyperthyroidism treated with methimazole. Bolaños F; González-Ortiz M; Durón H; Sánchez C Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954 [TBL] [Abstract][Full Text] [Related]
31. [On the residual thyroid tissue after thyroidectomy for diffuse goiter with thyrotoxicosis]. Angelescu E; Stoenescu D; Damian A; Taşcă C Stud Cercet Endocrinol; 1973; 24(6):465-71. PubMed ID: 4129363 [No Abstract] [Full Text] [Related]
32. Surgery for hyperthyroidism: indications, pretreatment, operative strategy and results. Roeher HD; Wahl R; Goretzki P; Branscheid D Ann Chir Gynaecol; 1983; 72(3):101-4. PubMed ID: 6194731 [TBL] [Abstract][Full Text] [Related]
34. [Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin]. Matiashina GI Vrach Delo; 1989 Apr; (4):31-3. PubMed ID: 2474220 [TBL] [Abstract][Full Text] [Related]
35. Long-term result of antithyroid drug therapy for Grave's disease: follow up after more than 5 years. Shizume K; Irie M; Nagataki S; Matsuzaki F; Shishiba Y Endocrinol Jpn; 1970 Oct; 17(5):327-32. PubMed ID: 4101380 [No Abstract] [Full Text] [Related]
36. [Chemotherapy of hyperthyroidism and its remission in Japan]. Ogata E; Igarashi T; Kimura T; Togawa K Horumon To Rinsho; 1974 Feb; 22(2):222-30. PubMed ID: 4136013 [No Abstract] [Full Text] [Related]
37. [Results of mercasolyl treatment of diffuse toxic goiter in children]. Saakian RP Pediatriia; 1975 Jul; (7):14-6. PubMed ID: 55996 [No Abstract] [Full Text] [Related]
38. [Results of follow-up over 5 years of Basedow's disease under medical management]. Shizume K Nihon Ishikai Zasshi; 1969 Sep; 62(5):435-41. PubMed ID: 4187803 [No Abstract] [Full Text] [Related]
39. [The use of succinate-containing preparations in combine therapy of diffuse toxic goiter]. Iakubovskii SV; Kondratenko GG; Popova II Klin Med (Mosk); 2014; 92(8):50-3. PubMed ID: 25790698 [TBL] [Abstract][Full Text] [Related]
40. Letter: Remission after therapy for Graves disease. Page LA JAMA; 1974 Feb; 227(6):659. PubMed ID: 4129716 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]